The value of post radiotherapy prostate specific antigen dynamics for prostate cancer risk stratification models

The value of post radiotherapy prostate specific antigen dynamics for prostate cancer risk stratification models

Background and purpose: Risk-stratification at diagnosis of prostate cancer does not always predict risk of biochemical recurrence (BCR). Fully utilizing post-radiotherapy follow-up Prostate Specific Antigen (PSA) data could offer earlier and higher prognostic value than pre-treatment risk-stratific...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jane Shortall, Eliana Vasquez Osorio, Andrew Green, Kimberley Reeves, David Wong, Tanuj Puri, Peter Hoskin, Ananya Choudhury, Marcel van Herk, Alan McWilliam
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Physics and Imaging in Radiation Oncology
Subjects:	Biochemical recurrence Follow-up Prostate cancer Prostate specific antigen Radiotherapy Risk-stratification
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405631625000922
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
by: See‐Tong Pang, et al.
Published: (2025-06-01)

Role of circulating MicroRNAs in prostate cancer diagnosis and risk stratification in the MCC Spain study
by: Inés Gómez-Acebo, et al.
Published: (2025-05-01)

Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
by: Gao X, et al.
Published: (2025-06-01)

Prostate cancer profile and risk stratification of patients treated at Universitas Annex Department of Oncology, Bloemfontein, Free State, during 2008 to 2010
by: Alicia Sherriff, et al.
Published: (2015-07-01)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
by: Aravintho Natarajan, et al.
Published: (2019-07-01)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024-09-01)

A strategy to reduce unnecessary prostate biopsies in patients with tPSA >10 ng ml−1 and PI-RADS 1–3
by: Qi-Fei Dong, et al.
Published: (2025-07-01)

Development and validation of a nomogram for predicting prostatic urethral involvement in bladder cancer
by: Hao Xu, et al.
Published: (2025-03-01)

Biochemical Recurrence in High-Risk Localized Prostate Cancer: A Comparison of Laparoscopic Prostatectomy and External Radiotherapy
by: Lubos Rybar, et al.
Published: (2025-05-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
by: Young Jun Uhm, et al.
Published: (2025-02-01)

Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy
by: Rui Su, et al.
Published: (2025-05-01)

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy
by: Valeria Pecci, et al.
Published: (2024-10-01)

Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer
by: Samaneh Eickelschulte, et al.
Published: (2025-06-01)

Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review
by: Soroush Rais-Bahrami, et al.
Published: (2025-05-01)

A NEW PARADIGM IN TREATMENT OF CHRONIC PROSTATITIS AS PREVENTION OF DEVELOPMENT OF PROSTATIC HYPERPLASIA
by: Y. G. Alyaev, et al.
Published: (2012-09-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Acute Bacterial Prostatitis – a review of current literature
by: Piotr Zając, et al.
Published: (2025-03-01)

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01)

Immunomodulation and Immunotherapy for Patients with Prostate Cancer: An Up-to-Date Review
by: Nigel P. Murray
Published: (2025-05-01)

Severe Xanthogranulomatous prostatitis mimicking prostate cancer: a case report
by: Wael Abdo Hassan, et al.
Published: (2024-12-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Integration of Genomic Tests in Prostate Cancer Care: Implications for Clinical Practice and Patient Outcomes
by: Christos Roidos, et al.
Published: (2024-12-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
by: Marcus Edward Asokendaran, et al.
Published: (2019-07-01)

Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
by: Manoj Gupta, et al.
Published: (2018-10-01)

Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer
by: Tommaso P. Tonelli, et al.
Published: (2024-12-01)

Prostatic artery embolization in treatment of benign prostatic hyperplasia: outcome and efficacy in medium-sized compared to large prostates
by: Noha Elghitany, et al.
Published: (2025-06-01)

Construction and validation of a lysine beta hydroxybutyrylation related molecular model for predicting biochemical recurrence of prostate cancer
by: Desheng Zhu, et al.
Published: (2025-08-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Understanding the Impact of Salvage Radiation on the Long‐Term Natural History of Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
by: Spyridon P. Basourakos, et al.
Published: (2025-07-01)

Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer
by: Karen A. Autio, et al.
Published: (2025-04-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
by: Yiji Peng, et al.
Published: (2025-03-01)

The older the better: The characteristic of localized prostate cancer in Chinese men
by: Haifeng Wang, et al.
Published: (2015-07-01)

Patients with small prostates and low-grade intravesical prostatic protrusion – A urodynamic evaluation
by: Han Jie Lee, et al.
Published: (2017-10-01)

THE SIGNIFICANCE OF PATHOMORPHOLOGICAL INVESTIGATION IN THE DIAGNOSIS OF PROSTATE TUBERCULOSIS
by: V. V. Potapov, et al.
Published: (2018-07-01)

DIFFERENTIAL DIAGNOSTICS OF PROSTATE TUBERCULOSIS
by: E. V. Brizhatyuk, et al.
Published: (2017-09-01)